ProfileGDS4718 / 204426_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 41% 39% 29% 31% 38% 45% 47% 34% 37% 40% 43% 35% 48% 56% 44% 54% 51% 41% 44% 27% 33% 37% 47% 44% 38% 45% 46% 31% 43% 26% 44% 38% 35% 46% 38% 50% 38% 30% 37% 33% 44% 39% 32% 44% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]5.039741
GSM549102patient 115, normal, homogenized [OPG study]4.9559139
GSM549104patient 119, normal, homogenized [OPG study]4.4778529
GSM549108patient 138, normal, homogenized [OPG study]4.6505731
GSM549119patient 077, normal, homogenized [OPG study]4.9102938
GSM549133patient 032, cancer, homogenized [OPG study]5.1921645
GSM549139patient 042, cancer, homogenized [OPG study]5.3155247
GSM549099patient 107, normal, homogenized [OPG study]4.7341634
GSM549109patient 139, normal, homogenized [OPG study]4.8476437
GSM549110patient 046, normal, homogenized [OPG study]5.0053140
GSM549114patient 063, normal, homogenized [OPG study]5.0749543
GSM549122patient 082, normal, homogenized [OPG study]4.76735
GSM549134patient 033, cancer, homogenized [OPG study]5.3788548
GSM549136patient 036, cancer, homogenized [OPG study]5.8484956
GSM549140patient 044, cancer, homogenized [OPG study]5.1740344
GSM549111patient 047, normal, homogenized [OPG study]5.7452154
GSM549113patient 057, normal, homogenized [OPG study]5.5388551
GSM549132patient 031, cancer, homogenized [OPG study]5.0131741
GSM549137patient 038, cancer, homogenized [OPG study]5.1500444
GSM549142patient 047, cancer, homogenized [OPG study]4.5156127
GSM549100patient 110, normal, homogenized [OPG study]4.6887833
GSM549107patient 135, normal, homogenized [OPG study]4.8333837
GSM549115patient 068, normal, homogenized [OPG study]5.3007847
GSM549116patient 072, normal, homogenized [OPG study]5.1639844
GSM549120patient 078, normal, homogenized [OPG study]4.8951938
GSM549131patient 030, cancer, homogenized [OPG study]5.1649345
GSM549118patient 074, normal, homogenized [OPG study]5.2827646
GSM549129patient 027, cancer, homogenized [OPG study]4.5980631
GSM549123patient 088, normal, homogenized [OPG study]5.1415343
GSM549124patient 006, cancer, homogenized [OPG study]4.4372626
GSM549126patient 015, cancer, homogenized [OPG study]5.1592544
GSM549128patient 025, cancer, homogenized [OPG study]4.8887238
GSM549103patient 117, normal, homogenized [OPG study]4.809435
GSM549117patient 073, normal, homogenized [OPG study]5.2511146
GSM549138patient 041, cancer, homogenized [OPG study]4.8639738
GSM549141patient 045, cancer, homogenized [OPG study]5.4567950
GSM549130patient 028, cancer, homogenized [OPG study]4.898238
GSM549101patient 111, normal, homogenized [OPG study]4.5575330
GSM549105patient 128, normal, homogenized [OPG study]4.8899537
GSM549106patient 134, normal, homogenized [OPG study]4.6254333
GSM549112patient 048, normal, homogenized [OPG study]5.1810144
GSM549125patient 011, cancer, homogenized [OPG study]4.9615339
GSM549127patient 024, cancer, homogenized [OPG study]4.6100132
GSM549135patient 035, cancer, homogenized [OPG study]5.1548544